Suppr超能文献

Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.

作者信息

Kaye D, Wenger N, Agarwal B

出版信息

Antimicrob Agents Chemother. 1978 Sep;14(3):318-21. doi: 10.1128/AAC.14.3.318.

Abstract

Cefazolin was added to dialysis fluid in nine patients with renal failure undergoing peritoneal dialysis with 2 liters/h per exchange. With 50 mg/liter (three patients), the first measurable mean serum concentration was 3.7 mug/ml (range, 2.4 to 4.9 mug/ml) after three exchanges and was 30.3 mug/ml (range, 13.3 to 44.3 mug/ml) after 24 exchanges. After 18 to 24 more exchanges without cefazolin, the mean serum concentration was 12.3 mug/ml (range, 3.8 to 24.6 mug/ml). The mean concentration in the dialysis outflow was 26.9 mug/ml (range, 2.5 to 58.5 mug/ml). With 150 mg/liter (six patients), the mean serum concentration was 5.2 mug/ml (range, 3.6 to 7.8 mug/ml) after the first exchange and 8.4 (range, 6.1 to 14.0 mug/ml), 15.0 (range, 8.2 to 23.5 mug/ml), and 71.9 (range, 26.2 to 142.1 mug/ml) mug/ml after the second, third, and twenty-fourth exchanges, respectively. After 17 to 24 more exchanges without cefazolin, the mean serum concentration was 38.2 mug/ml (range, 15.4 to 65.7 mug/ml). The mean concentration in the dialysis outflow was 71.4 mug/ml (range, 21.9 to 150.8 mug/ml). After 1 g of cefazolin was given intraperitoneally with no more dialysis, serum concentrations rose by a mean of 62.5 mug/ml (range, 18.9 to 107.8 mug/ml). The maximum rise occurred within 2 h with two-thirds of the rise occurring within 30 min. During the subsequent 22 h levels dropped to 65.4% of the peak.

摘要

相似文献

1
Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.
Antimicrob Agents Chemother. 1978 Sep;14(3):318-21. doi: 10.1128/AAC.14.3.318.
2
Effects of renal failure and dialysis on cefazolin pharmacokinetics.
Antimicrob Agents Chemother. 1975 Jul;8(1):63-6. doi: 10.1128/AAC.8.1.63.
3
Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Perit Dial Int. 2017 Mar-Apr;37(2):218-224. doi: 10.3747/pdi.2015.00300. Epub 2016 Oct 13.
4
Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
Perit Dial Int. 2020 Mar;40(2):179-184. doi: 10.1177/0896860819893820. Epub 2020 Jan 17.
6
Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.
J Clin Pharmacol. 1977 Feb-Mar;17(2-3):128-33. doi: 10.1002/j.1552-4604.1977.tb04599.x.
7
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1983 Jan;33(1):66-72. doi: 10.1038/clpt.1983.9.
10
Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:263-7. doi: 10.1093/jac/12.suppl_a.263.

引用本文的文献

1
Peritoneal absorption of moxalactam.
Antimicrob Agents Chemother. 1983 Jul;24(1):39-41. doi: 10.1128/AAC.24.1.39.
2
Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.
Clin Pharmacokinet. 1985 Sep-Oct;10(5):404-25. doi: 10.2165/00003088-198510050-00003.

本文引用的文献

1
The passage of cephalothin into and out of ascitic fluid.
Am J Med Sci. 1967 Apr;253(4):449-52. doi: 10.1097/00000441-196704000-00007.
2
Irrigation of the peritoneal cavity with cephalothin.
Am J Surg. 1972 Feb;123(2):192-5. doi: 10.1016/0002-9610(72)90332-7.
3
Pharmacokinetics of cefazolin in normal and uremic subjects.
Clin Pharmacol Ther. 1974 Apr;15(4):344-53. doi: 10.1002/cpt1974154344.
4
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.
Antimicrob Agents Chemother. 1973 Feb;3(2):168-74. doi: 10.1128/AAC.3.2.168.
5
Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.
Antimicrob Agents Chemother. 1973 Sep;4(3):366-71. doi: 10.1128/AAC.4.3.366.
6
Pharmacology of cefazolin in patients with normal and abnormal renal function.
J Infect Dis. 1973 Oct;128:Suppl:S354-7. doi: 10.1093/infdis/128.supplement_2.s354.
7
Prophylaxis with cephalothin in peritoneal dialysis.
Arch Intern Med. 1973 Sep;132(3):368-71.
8
Effects of renal failure and dialysis on cefazolin pharmacokinetics.
Antimicrob Agents Chemother. 1975 Jul;8(1):63-6. doi: 10.1128/AAC.8.1.63.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验